Novel compounds of the formula I in which X, Y, Z, R, R1, R2
and R3 are as defined in Patent Claim 1, are inhibitors
of coagulation factor Xa and can be employed for the prophylaxis and/or therapy
of tromboembolic diseases and for the treatment of tumors
##STR1##
